| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $4,402,775 | 5 | 33 |
Sells | $47,538,624 | 10 | 67 |
| Ford Robert B | CHAIRMAN AND CEO | 1 | $2.01M | 1 | $46.2M | $-44.19M |
| STARKS DANIEL J | director | 2 | $2.01M | 0 | $0 | $2.01M |
| Boudreau Philip P | EVP AND CFO | 1 | $201,300 | 0 | $0 | $201,300 |
| Stratton John G | director | 1 | $173,640 | 0 | $0 | $173,640 |
| Cushman Elizabeth C. | EVP, GC AND SECRETARY | 0 | $0 | 1 | $30,398 | $-30,398 |
| MCCOY JOHN A. JR. | VICE PRESIDENT AND CONTROLLER | 0 | $0 | 2 | $70,572 | $-70,572 |
| Moreland Mary K | EXECUTIVE VICE PRESIDENT | 0 | $0 | 1 | $70,851 | $-70,851 |
| Salvadori Daniel Gesua Sive | EVP AND GROUP PRESIDENT | 0 | $0 | 1 | $102,288 | $-102,288 |
| Shroff Eric | Senior Vice President | 0 | $0 | 2 | $284,989 | $-284,989 |
| Morrone Louis H. | EXECUTIVE VICE PRESIDENT | 0 | $0 | 2 | $774,729 | $-774,729 |
Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of health solutions. The company operates through four primary divisions: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. In the Established Pharmaceutical Products segment, Abbott provides generic medications designed to treat a wide array of conditions, including pancreatic exocrine insufficiency, …
Over the last 12 months, insiders at Abbott Laboratories have bought $4.4M and sold $47.54M worth of Abbott Laboratories stock.
On average, over the past 5 years, insiders at Abbott Laboratories have bought $4.4M and sold $53.63M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Ford Robert B (CHAIRMAN AND CEO) — $2.01M. STARKS DANIEL J (director) — $2.01M. Boudreau Philip P (EVP AND CFO) — $201,300.
The last purchase of 2,000 shares for transaction amount of $173,640 was made by Stratton John G (director) on 2026‑05‑07.
| 2026-09-02 | Sale | MCCOY JOHN A. JR. | VICE PRESIDENT AND CONTROLLER | 27 <0.0001% | $109.54 | $2,958 | -7.06% | |
| 2026-08-25 | Sale | Ford Robert B | CHAIRMAN AND CEO | 398,832 0.023% | $115.85 | $46.2M | -11.33% | |
| 2026-08-11 | Sale | Morrone Louis H. | EXECUTIVE VICE PRESIDENT | 5,850 0.0003% | $109.83 | $642,506 | -5.49% | |
| 2026-05-07 | Stratton John G | director | 2,000 0.0001% | $86.82 | $173,640 | +16.94% | ||
| 2026-04-27 | STARKS DANIEL J | director | 10,000 0.0006% | $92.65 | $926,537 | +9.20% | ||
| 2026-04-23 | Boudreau Philip P | EVP AND CFO | 2,200 0.0001% | $91.50 | $201,300 | +9.52% | ||
| 2026-03-02 | Sale | Salvadori Daniel Gesua Sive | EVP AND GROUP PRESIDENT | 885 <0.0001% | $115.58 | $102,288 | -10.29% | |
| 2026-03-02 | Sale | Moreland Mary K | EXECUTIVE VICE PRESIDENT | 613 <0.0001% | $115.58 | $70,851 | -10.29% | |
| 2026-03-02 | Sale | Morrone Louis H. | EXECUTIVE VICE PRESIDENT | 1,144 <0.0001% | $115.58 | $132,224 | -10.29% | |
| 2026-03-02 | Sale | Shroff Eric | Senior Vice President | 709 <0.0001% | $115.58 | $81,946 | -10.29% | |
| 2026-03-02 | Sale | Cushman Elizabeth C. | EVP, GC AND SECRETARY | 263 <0.0001% | $115.58 | $30,398 | -10.29% | |
| 2026-03-02 | Sale | MCCOY JOHN A. JR. | VICE PRESIDENT AND CONTROLLER | 585 <0.0001% | $115.58 | $67,614 | -10.29% | |
| 2026-02-04 | STARKS DANIEL J | director | 10,000 0.0006% | $108.73 | $1.09M | -4.46% | ||
| 2026-01-23 | Ford Robert B | CHAIRMAN AND CEO | 18,800 0.0011% | $107.13 | $2.01M | -3.44% | ||
| 2025-11-25 | Sale | Shroff Eric | Senior Vice President | 1,586 <0.0001% | $128.02 | $203,043 | -17.22% | |
| 2025-08-08 | Sale | Boudreau Philip P | EVP AND CFO | 5,550 0.0003% | $134.55 | $746,758 | -15.45% | |
| 2025-04-30 | Sale | Blount Sally E. | director | 2,600 0.0001% | $129.66 | $337,116 | -1.97% | |
| 2025-03-07 | Sale | Earnhardt Lisa D | EVP AND GROUP PRESIDENT | 200 <0.0001% | $136.65 | $27,329 | -4.99% | |
| 2025-03-06 | Sale | Earnhardt Lisa D | EVP AND GROUP PRESIDENT | 91,167 0.0052% | $133.82 | $12.2M | -3.55% | |
| 2025-03-03 | Sale | Moreland Mary K | EXECUTIVE VICE PRESIDENT | 791 <0.0001% | $138.17 | $109,292 | -6.96% |
| STARKS DANIEL J | director | 6751103 0.3902% | $738.57M | 3 | 6 | +9.73% |
| Ford Robert B | CHAIRMAN AND CEO | 306461 0.0177% | $33.53M | 2 | 6 | +25.66% |
| Stratton John G | director | 23319 0.0013% | $2.55M | 2 | 0 | +14.85% |
| Boudreau Philip P | EVP AND CFO | 2200 0.0001% | $240,680.00 | 1 | 4 | |
| WHITE MILES D | Chairman and CEO | 3174165 0.1834% | $347.25M | 2 | 20 | +6.92% |
| Fussell Stephen R | Executive Vice President | 169935 0.0098% | $18.59M | 1 | 44 | +19.1% |
| Blaser Brian J | Executive Vice President | 130745 0.0076% | $14.3M | 1 | 23 | +28.34% |
| WOODGRIFT RANDEL WILLIAM | SENIOR VICE PRESIDENT | 52203 0.003% | $5.71M | 1 | 10 | +13.26% |
| Doyle Katherine C. | Senior Vice President | 43474 0.0025% | $4.76M | 3 | 3 | +8.94% |
| NOVAKOVIC PHEBE N | director | 41004 0.0024% | $4.49M | 1 | 2 | +11.41% |
| OSBORN WILLIAM A | director | 34476 0.002% | $3.77M | 4 | 0 | +4.19% |
| Blount Sally E. | director | 34058 0.002% | $3.73M | 1 | 2 | +16.02% |
| LIDDY EDWARD M | director | 22967 0.0013% | $2.51M | 1 | 0 | +21.33% |
| TILTON GLENN F | director | 10647 0.0006% | $1.16M | 2 | 0 | <0.0001% |
| SCOTT SAMUEL C III | director | 7730 0.0004% | $845,662.00 | 1 | 0 | <0.0001% |
| Kumbier Michelle | director | 7296 0.0004% | $798,182.40 | 1 | 0 | +1.4% |
| DALEY WILLIAM M | director | 5389 0.0003% | $589,556.60 | 3 | 0 | +0.82% |
| FARRELL W JAMES | director | 1000 0.0001% | $109,400.00 | 1 | 0 | +11.49% |
| Increased Positions | 1,498 | +41.55% | 71M | +5.15% |
| Decreased Positions | 1,573 | -43.63% | 55M | -3.98% |
| New Positions | 308 | New | 13M | New |
| Sold Out Positions | 179 | Sold Out | 5M | Sold Out |
| Total Postitions | 3,530 | -2.08% | 1B | +1.17% |
| Vanguard Group Inc | $21.5M | 9.96% | 173.15M | +353,457 | +0.2% | 2025-09-30 |
| Blackrock, Inc. | $17.58M | 8.14% | 141.56M | +272,930 | +0.19% | 2025-09-30 |
| State Street Corp | $9.71M | 4.5% | 78.23M | -128,279 | -0.16% | 2025-09-30 |
| Capital International Investors | $7.65M | 3.54% | 61.61M | +1M | +2.46% | 2025-09-30 |
| Capital Research Global Investors | $4.81M | 2.23% | 38.77M | -3M | -7.18% | 2025-09-30 |
| Morgan Stanley | $4.8M | 2.22% | 38.63M | +3M | +9.74% | 2025-09-30 |
| Geode Capital Management, Llc | $4.79M | 2.22% | 38.54M | +248,827 | +0.65% | 2025-09-30 |
| Jpmorgan Chase & Co | $3.65M | 1.69% | 29.38M | -10M | -25.24% | 2025-09-30 |
| Wellington Management Group Llp | $2.89M | 1.34% | 23.25M | -2M | -7.2% | 2025-09-30 |
| Norges Bank | $2.76M | 1.28% | 22.25M | +1M | +6.03% | 2025-06-30 |